|
BUSINESS
RESPONSIBLE CARE UNDER REVIEW
Evaluation seeks consistency in industry safety and environmental ethic
|
 |
|
Campbell
ACC PHOTO |
|
 |
|
Lebedev
ACC PHOTO |
|
|
Organizers hope to get leaders of multinational firms to push for consistent, fundamental principles. Currently, 47 individual country associations promote their distinctive versions of the program.
Michael E. Campbell, Arch Chemicals CEO, told reporters at the American Chemistry Council Responsible Care Conference last week that Responsible Care "means something different in each country. We want to look at the essential aspects and bring vitality back to the program." Campbell, elected vice chairman of ACC late last month, is one of the leaders of the strategic review.
Solvay CEO Aloïs Michielsen will convene the upcoming ICCA gathering. He characterizes the review as "a strong sign that we regard [Responsible Care] as a key driver of industry activity." Undertaking the review, he says, will "help raise public confidence in the good management of chemicals throughout their life cycle."
Review participants will include Crompton Corp. CEO Vincent A. Calarco, Borealis Chief Executive John Taylor, and Pedro Wongtschowski, managing director of Brazil's Oxiteno. Leaders of major associations will also take part, including Alain Perroy, director general of the European Chemical Industry Council (CEFIC); Masami Tanaka, director general of the Japan Chemical Industry Association; and Greg Lebedev, ACC's CEO.
"In many countries, Responsible Care is stuck at the mid-management level in environment, health, and safety," according to Brian R. Wastle, vice president of the Canadian Chemical Producers' Association. "But Responsible Care is an ethical culture that has to start at the top." |